Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Advanced Surgical Institute at Mercy Hospital
mi
from
Miami, FL
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Advanced Surgical Institute at Mercy Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Cleveland Clinic Florida
mi
from
Weston, FL
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Hamilton Medical Center - Weight Management
mi
from
Dalton, GA
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Hamilton Medical Center - Weight Management
mi
from
Dalton, GA
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Weight Management Center
mi
from
New Orleans, LA
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Weight Management Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
CAREMAX Surgical, P.C.
mi
from
East Patchogue, NY
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
CAREMAX Surgical, P.C.
mi
from
East Patchogue, NY
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated:  8/3/2015
Surgical Consultants of San Antonio
mi
from
San Antonio, TX
Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
A Single-Arm, Multi-Center Study of the Safety and Effectiveness of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
Status: Enrolling
Updated: 8/3/2015
Surgical Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Innovative Approaches to Diet, Exercise and Activity
Enhanced Behavioral Intervention to Improve Long-Term Weight Loss in Young Adults
Status: Enrolling
Updated:  8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Innovative Approaches to Diet, Exercise and Activity
Enhanced Behavioral Intervention to Improve Long-Term Weight Loss in Young Adults
Status: Enrolling
Updated: 8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
Status: Enrolling
Updated:  8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
Status: Enrolling
Updated: 8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention
The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention
Status: Enrolling
Updated:  8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention
The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention
Status: Enrolling
Updated: 8/4/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Single Incision Laparoscopic Gastric Banding Versus Conventional Five Port Laparoscopic Gastric Banding
Single Incision Laparoscopic Gastric Banding Versus Conventional Five Port Laparoscopic Gastric Banding
Status: Enrolling
Updated:  8/5/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Single Incision Laparoscopic Gastric Banding Versus Conventional Five Port Laparoscopic Gastric Banding
Single Incision Laparoscopic Gastric Banding Versus Conventional Five Port Laparoscopic Gastric Banding
Status: Enrolling
Updated: 8/5/2015
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Macronutrient Regulation of Ghrelin and Peptide YY
Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children With Prader-Willi Syndrome (PWS) and Children With Hypothalamic-Derived Obesity: Macronutrient Regulation Sub-study
Status: Enrolling
Updated:  8/6/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Macronutrient Regulation of Ghrelin and Peptide YY
Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children With Prader-Willi Syndrome (PWS) and Children With Hypothalamic-Derived Obesity: Macronutrient Regulation Sub-study
Status: Enrolling
Updated: 8/6/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Evansville, IN
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Lexington, KY
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Louisville, KY
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
New Orleans, LA
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Milford, MA
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Milford, MA
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Manlius, NY
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Manlius, NY
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Warwick, RI
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Mt Pleasant, SC
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Mt Pleasant, SC
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Nashville, TN
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Dallas, TX
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Odessa, TX
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Odessa, TX
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Norfolk, VA
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Wauwatosa, WI
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated:  8/7/2015
Clinical Research Facility
mi
from
Meridian, ID
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Efficacy of the Co-administration of Canagliflozin 300 mg and Phentermine 15 mg Compared With Placebo for the Treatment of Non-diabetic Overweight and Obese Subjects
Status: Enrolling
Updated: 8/7/2015
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men
The Effect of Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men.
Status: Enrolling
Updated:  8/10/2015
Institute of Sports Science and Medicine, Florida State University
mi
from
Tallahassee, FL
Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men
The Effect of Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men.
Status: Enrolling
Updated: 8/10/2015
Institute of Sports Science and Medicine, Florida State University
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Status: Enrolling
Updated:  8/10/2015
Harry S. Truman Memorial Veterans' Hospital
mi
from
Columbia, MO
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Status: Enrolling
Updated: 8/10/2015
Harry S. Truman Memorial Veterans' Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population
Status: Enrolling
Updated:  8/11/2015
Brody Outpatient of Brody Medical Sciences Module D
mi
from
Greenville, NC
The Effect of Phentermine and B12 on Weight Loss Among Obese Patients
A Pilot Study to Assess Whether the Combination of Phentermine and B12 Has a Significant Effect on Weight Loss Among an Obese Study Population
Status: Enrolling
Updated: 8/11/2015
Brody Outpatient of Brody Medical Sciences Module D
mi
from
Greenville, NC
Click here to add this to my saved trials
Adaptation of the Diabetes Prevention Program for Primary Care
Adaptation of the Diabetes Prevention Program for Primary Care
Status: Enrolling
Updated:  8/12/2015
Center for Human Nutrition
mi
from
Denver, CO
Adaptation of the Diabetes Prevention Program for Primary Care
Adaptation of the Diabetes Prevention Program for Primary Care
Status: Enrolling
Updated: 8/12/2015
Center for Human Nutrition
mi
from
Denver, CO
Click here to add this to my saved trials
Geisinger Education Intervention Study in Obesity Protocol
Geisinger Education Intervention Study in Obesity Protocol
Status: Enrolling
Updated:  8/14/2015
Geisinger Health System
mi
from
Danville, PA
Geisinger Education Intervention Study in Obesity Protocol
Geisinger Education Intervention Study in Obesity Protocol
Status: Enrolling
Updated: 8/14/2015
Geisinger Health System
mi
from
Danville, PA
Click here to add this to my saved trials
Incentives for Moving
Status: Enrolling
Updated:  8/17/2015
Blue Shield of California
mi
from
San Francisco, CA
Incentives for Moving
Status: Enrolling
Updated: 8/17/2015
Blue Shield of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Testing Strategies for Increasing Exercise
Testing Strategies for Increasing Exercise
Status: Enrolling
Updated:  8/17/2015
Blue Cross Blue Shield Massachusetts
mi
from
Boston, MA
Testing Strategies for Increasing Exercise
Testing Strategies for Increasing Exercise
Status: Enrolling
Updated: 8/17/2015
Blue Cross Blue Shield Massachusetts
mi
from
Boston, MA
Click here to add this to my saved trials
Outcomes of Bariatric Surgery/UMMMC Bariatric Surgery Registry
Outcomes of Bariatric Surgery (UMMMC Bariatric Surgery Registry)
Status: Enrolling
Updated:  8/17/2015
UMASS Memorial Medical Center
mi
from
Worcester, MA
Outcomes of Bariatric Surgery/UMMMC Bariatric Surgery Registry
Outcomes of Bariatric Surgery (UMMMC Bariatric Surgery Registry)
Status: Enrolling
Updated: 8/17/2015
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Valparaiso, IN
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Hyannis, MA
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Hyannis, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Saint Paul, MN
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Augusta, GA
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Louisville, KY
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
New York, NY
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
High Point, NC
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Norfolk, VA
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated:  8/19/2015
Clinical Research Facility
mi
from
Richmond, VA
A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Status: Enrolling
Updated: 8/19/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Prepackaged Foods to Promote Weight Loss
Randomized Clinical Trial of Portion-Controlled Prepackaged Foods to Promote Weight Loss - CHOICES Study.
Status: Enrolling
Updated:  8/19/2015
The University of California, San Diego
mi
from
La Jolla, CA
Prepackaged Foods to Promote Weight Loss
Randomized Clinical Trial of Portion-Controlled Prepackaged Foods to Promote Weight Loss - CHOICES Study.
Status: Enrolling
Updated: 8/19/2015
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials